Global Competition for the Best Location Policy in Europe

The German (biotech) industry is in a global competition with many large biotech nations. EU regulations, such as the IVDR, CT Regulation, Novel Food Regulation or the outdated Genetic Engineering Law inhibit innovative research and development in Europe. In addition, countries such as the USA, the largest biotech market in the world, offer excellent settlement conditions. How can the German biotech industry hold its own in global competition?